Literature DB >> 965496

Lead poisoning: association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine 5'-nucleotidase deficiency, and intraerythrocytic accumulation of pyrimidines.

W N Valentine, D E Paglia, K Fink, G Madokoro.   

Abstract

Lead intoxication is accompanied by an acquired deficiency of erythrocyte pryimidine-specific, 5'-nucleotidase. Genetically determined deficiency of this enzyme is associated with chronic hemolysis, marked basophilic stippling of erythrocytes on stained blood films, and unique intraerythrocytic accumulations of pyrimidine-containing nucleotides. The present report documents that lead-induced deficiency when sufficiently severe gives rise to findings similar to the hereditary disorder. Whereas pyrimidine-containing nucleotides are virutally absent in the erythrocytes of normal and reticulocyte-rich blood, 12% of erythrocyte nucloetides in the blood of a patient with lead intoxication contained cytidine. Nucleotidase activity was about 25% that in normal erythrocytes and 15% or less of that expected in comparable reticulocyte-rich blood. The distribution of nucleotidase activity in patient erythrocytes is unknown, and much more severe deficiency could have been present in subsets of the cell populations analyzed. The findings indicate that the hemolytic anemia and increased basophilic stippling characteristic of certain cases of lead intoxication may share a common etiology with essentially identical features of the genetically determined disorder.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 965496      PMCID: PMC333255          DOI: 10.1172/JCI108545

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  STUDIES ON CHROMATED ERYTHROCYTES. EFFECT OF SODIUM CHROMATE ON ERYTHROCYTE GLUTATHIONE REDUCTASE.

Authors:  G A KOUTRAS; M HATTORI; A S SCHNEIDER; F G EBAUGH; W N VALENTINE
Journal:  J Clin Invest       Date:  1964-02       Impact factor: 14.808

2.  HEREDITARY HEMOLYTIC ANEMIA WITH TRIOSEPHOSPHATE ISOMERASE DEFICIENCY.

Authors:  A S SCHNEIDER; W N VALENTINE; M HATTORI; H L HEINS
Journal:  N Engl J Med       Date:  1965-02-04       Impact factor: 91.245

3.  AN ELECTRON MICROSCOPIC DESCRIPTION OF BASOPHILIC STIPPLING IN RED CELLS.

Authors:  W N JENSEN; G D MORENO; M C BESSIS
Journal:  Blood       Date:  1965-06       Impact factor: 22.113

4.  Human red cell glycolytic intermediates.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

5.  Improved method for the determination of blood glutathione.

Authors:  E BEUTLER; O DURON; B M KELLY
Journal:  J Lab Clin Med       Date:  1963-05

6.  Changes in the nucleotides of stored or incubated human blood.

Authors:  C BISHOP
Journal:  Transfusion       Date:  1961 Nov-Dec       Impact factor: 3.157

7.  Simultaneous multiple-column chromatography: its application to the separation of the adenine nucleotides of human erythrocytes.

Authors:  C DE LUCA; J H STEVENSON; E KAPLAN
Journal:  Anal Biochem       Date:  1962-07       Impact factor: 3.365

8.  The nucleotides in normal human blood.

Authors:  C BISHOP; D M RANKINE; J H TALBOTT
Journal:  J Biol Chem       Date:  1959-05       Impact factor: 5.157

9.  The metabolism of nucleotides and other phosphate esters in erythrocytes during in vitro incubation at 37 degrees.

Authors:  G C MILLS; L B SUMMERS
Journal:  Arch Biochem Biophys       Date:  1959-09       Impact factor: 4.013

10.  [Free nucleotides in red blood cells and reticulocytes].

Authors:  P MANDEL; P CHAMBON; H KARON; I KULIC; M SERTER
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1962
View more
  18 in total

Review 1.  Recognition and management of children with increased lead absorption.

Authors:  J J Chisolm; D Barltrop
Journal:  Arch Dis Child       Date:  1979-04       Impact factor: 3.791

Review 2.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 3.  Structures of proteins of biomedical interest from the Center for Eukaryotic Structural Genomics.

Authors:  George N Phillips; Brian G Fox; John L Markley; Brian F Volkman; Euiyoung Bae; Eduard Bitto; Craig A Bingman; Ronnie O Frederick; Jason G McCoy; Betsy L Lytle; Brad S Pierce; Jikui Song; Simon N Twigger
Journal:  J Struct Funct Genomics       Date:  2007-09-06

Review 4.  [Rare diseases recognizable from blood smears].

Authors:  J Hoffmann; C Michel; T Schindler; E Wollmer; A Neubauer
Journal:  Internist (Berl)       Date:  2018-10       Impact factor: 0.743

5.  Identification of thymidine nucleotidase and deoxyribonucleotidase activities among normal isozymes of 5'-nucleotidase in human erythrocytes.

Authors:  D E Paglia; W N Valentine; R A Brockway
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

6.  A role of red cell pyrimidine 5'-nucleotidase in experimental lead poisoning.

Authors:  H Fujii
Journal:  Arch Toxicol       Date:  1979-10       Impact factor: 5.153

7.  Lead poisoning. Further observations on erythrocyte pyrimidine-nucleotidase deficiency and intracellular accumulation of pyrimidine nucleotides.

Authors:  D E Paglia; W N Valentine; K Fink
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

8.  Erythrocyte pyrimidine 5'-nucleotidase activity in workers exposed to lead, mercury or cadmium.

Authors:  B Mohammed-Brahim; J P Buchet; R Lauwerys
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

9.  Lead poisoning: clinical, biochemical, and haematological aspects of a recent outbreak.

Authors:  A Pagliuca; G J Mufti; D Baldwin; A N Lestas; R M Wallis; A J Bellingham
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

10.  Evaluation of lead exposure in workers at a lead-acid battery factory in Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).

Authors:  Y Kim; K Harada; S Ohmori; B K Lee; H Miura; A Ueda
Journal:  Occup Environ Med       Date:  1995-07       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.